21 - 40 of about 101
English: Wada N, Shimizu T, Shimizu N, Kurobe M, de Groat WC, Tyagi P, Kakizaki H, Yoshimura N., Therapeutic effects of inhibition of brain-derived neurotrophic factor on voiding dysfunction in mice with spinal cord injury. , Am. J. Physiol. Renal Physiol. , vol.317 (5) (p.F1305 - F1310) , 2019
English: Kakizaki H, Lee K-S, Yamamoto O, Jong JJ, Katou D, Sumarsono B, Uno S, Yamaguchi O.:, Mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A randomized, placebo-controlled study (MATCH). , European Urology Focus , 2019
English: Yoshida M, Kakizaki H, Takahashi S, Nagai S, Kurose T., Long-term safety and efficacy of the novel β3-adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study. , International Journal of Urology , vol.25 (7) (p.668 - 675) , 2018
English: Wada N, Watanabe M, Banjo H, Tsuchida M, Hori G, Tamaki G, Azumi M, Kita M, Kakizaki H., A long-term persistence with mirabegron in a real world clinical setting. , International Journal of Urology , vol.25 (5) (p.501 - 506) , 2018
English: Hori J, Koga D, Kakizaki H, Watanabe T., Differential effects of depot formulations of GnRH agonist leuprorelin and antagonist degarelix on the seminiferous epithelium of the rat testis. , Biomedical Research , vol.39 (4) (p.197 - 214) , 2018
English: Wada N, Shimizu T, Shimizu N, de Groat WC, Kanai AJ, Tyagi P, Kakizaki H, Yoshimura N., The effect of neutralization of nerve growth factor (NGF) on bladder and urethral dysfunction in mice with spinal cord injury. , Neurourology and Urodynamics , 2018
English: Wada N, Kadekawa K, Majima T, Shimizu T, Tyagi P, Kakizaki H, Yoshimura N., Urodynamic effects of intravenous and intrathecal administration of E-series prostaglandin 1 receptor antagonist on detrusor overactivity in rats with spinal cord injury. , Neurourology and Urodynamics , vol.37 (1) (p.132 - 137) , 2018
English: Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A and Kuroishi K., Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI Ⅱ study) , International Journal of Urology , 2018
English: Rosier PFW, Kuo HC, De Gennaro M, Gammie A, Agro EF, Kakizaki H,Hashim H, Toozs-Hobson P., International Consultation on Incontinence 2016; Executive summary: Urodynamic testing. , Neurourology and Urodynamics , 2018
English: Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Hashimoto K and Minemura K., Efficacy of novel β3-adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study. , International Journal of Urology , 2018
English: Hori J, Kobayashi S, Tamaki G, Azumi M, Kakizaki H., Diagnostic efficacy of percutaneous renal tumor biopsy –Concomitant use of frozen section to accurately diagnose renal tumor with necrosis. , Japanese Journal of Cancer Chemotherapy , vol.44 (9) (p.771 - 774) , 2017
English: Wada N, Shimizu T, Takai S, Shimizu N, Kanai AJ, Tyagi P, Kakizaki H, Yoshimura N., Post-injury management strategy influences lower urinary tract dysfunction in the mouse model of spinal cord injury , Neurourology and Urodynamics , vol.36 (5) (p.1301 - 1305) , 2017
English: Wada N, Shimizu T, Takai S, Shimizu N, Tyagi P, Kakizaki H, Yoshimura N, Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinalcord injury , Neurourology and Urodynamics , vol.36 (4) (p.1039 - 1045) , 2017
English: Hori J, Wada N, Tamaki G, Azumi M, Kita M, Iwata T, Matsumoto S, Kakizaki H., Combination of GnRH antagonist degarelix and antiandrogen is effective in PSA reduction and bone management in patients with prostate cancer. , Japanese Journal of Cancer Chemotherapy , vol.43 (6) (p.727 - 731) , 2016
English: Wada N, Iuchi H, Kita M, et al, Urodynamic efficacy and safety of mirabegron add-on treatment with tamsulosin for Japanese male patients with overactive bladder , LUTS , 2016 , (IF:0.239)
English: Wada N, Hashizume K, Matsumoto S, Kakizaki H., Dutasteride improves bone mineral density in male patients with lower urinary tractsymptoms and prostatic enlargement: a preliminary study , Aging Male , 2016
English: Watanabe M, Suzuki Y, Uchida K, et al, Trpm7 contributes to intercellular junction formation in mouse urothelium , J Biol Chem , vol.290 (50) (p.29882 - 29892) , 2015
English: Wada N, Ameda K, Furuno T, Okada H, Date I, Kakizaki H, Evaluation of Prostaglandin E2 and E-series prostaglandin receptor in patients with intetstitial cystitis , The Journalof Urology , vol.193 (6) (p.1987 - 1993) , 2015 , (IF:3.746)
English: Seiji Matsumoto, et al, Association between chronic periodontal disease and lower urinary tract symptoms in both sexes , LUTS , vol.7 (1) (p.17 - 21) , 2015
English: Naoki Wada, et al, Improvement of overactive bladder symptoms and bladder ischemia with dutasteride in patients with benign prostatic enlargement , LUTS , vol.7 (1) (p.37 - 41) , 2015
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.